98 related articles for article (PubMed ID: 7048246)
1. [Clinical trial of isaxonine in diabetic neuropathies (author's transl)].
Augustin P; Rathery M
Nouv Presse Med; 1982 Apr; 11(16):1265-8. PubMed ID: 7048246
[TBL] [Abstract][Full Text] [Related]
2. [Clinical trial of isaxonine in the ulcerous mutilating acropathy of chronic alcoholics (author's transl)].
Barrière H
Nouv Presse Med; 1982 Apr; 11(16):1275-7. PubMed ID: 7048248
[TBL] [Abstract][Full Text] [Related]
3. [Protective effect of isaxonine against vincristine-induced neuropathy (author's transl)].
Duhamel G; Parlier Y
Nouv Presse Med; 1982 Apr; 11(16):1254-6. PubMed ID: 6285279
[TBL] [Abstract][Full Text] [Related]
4. [Controlled trial of isaxonine in traumatic or ischaemic (compression) neuropathies (author's transl)].
Cambier J; Dordain G
Nouv Presse Med; 1982 Apr; 11(16):1272-4. PubMed ID: 6285280
[TBL] [Abstract][Full Text] [Related]
5. [Clinical and electrophysiological study of isaxonine in peripheral facial paralysis (author's transl)].
Dehen H
Nouv Presse Med; 1982 Apr; 11(16):1262-4. PubMed ID: 6896576
[TBL] [Abstract][Full Text] [Related]
6. [Clinical trial of isaxonine in alcoholic polyneuritis (author's transl)].
Passouant P; Cadilhac J
Nouv Presse Med; 1982 Apr; 11(16):1269-71. PubMed ID: 7048247
[TBL] [Abstract][Full Text] [Related]
7. [Acceleration by isaxonine of muscle reinnervation. Electrophysiological demonstration in leprotic neuropathy (author's transl)].
Sebille A; Saint-André P; Hugelin A
Nouv Presse Med; 1982 Apr; 11(16):1278-80. PubMed ID: 6285281
[TBL] [Abstract][Full Text] [Related]
8. Selection of patients with symptomatic diabetic neuropathy for clinical trials.
Krentz AJ; Honigsberger L; Nattrass M
Diabete Metab; 1989; 15(6):416-9. PubMed ID: 2628043
[TBL] [Abstract][Full Text] [Related]
9. [A molecule active in deficiency and metabolic neuropathies].
Med Chir Dig; 1982; 11(4):305-6. PubMed ID: 6287127
[No Abstract] [Full Text] [Related]
10. Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.
Rauck RL; Shaibani A; Biton V; Simpson J; Koch B
Clin J Pain; 2007 Feb; 23(2):150-8. PubMed ID: 17237664
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy.
Sachse G; Willms B
Horm Metab Res Suppl; 1980; 9():105-7. PubMed ID: 6769773
[TBL] [Abstract][Full Text] [Related]
12. [Study of the effects of isaxonine on retrograde axon degeneration induced by vincristine in man (author's transl)].
Guiheneuc P; Ginet J; Grolleau JY; Rojouan J
Nouv Presse Med; 1982 Apr; 11(16):1257-61. PubMed ID: 6896575
[TBL] [Abstract][Full Text] [Related]
13. Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy.
Chadda VS; Mathur MS
J Assoc Physicians India; 1978 May; 26(5):403-6. PubMed ID: 365857
[No Abstract] [Full Text] [Related]
14. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
[TBL] [Abstract][Full Text] [Related]
15. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.
Ekberg K; Brismar T; Johansson BL; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Diabetes Care; 2007 Jan; 30(1):71-6. PubMed ID: 17192336
[TBL] [Abstract][Full Text] [Related]
16. [Contribution of motor nerve conduction velocity and Hoffmann reflex in early detection of neuropathy in diabetics. Results and correlations with duration and other long-term complications in 117 patients (author's transl)].
Mabin D; Darragon T; Morin JF; Bercovici JP
Diabete Metab; 1980 Jun; 6(2):109-15. PubMed ID: 7409294
[TBL] [Abstract][Full Text] [Related]
17. Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.
Brooks B; Delaney-Robinson C; Molyneaux L; Yue DK
J Diabetes Complications; 2008; 22(2):88-95. PubMed ID: 18280438
[TBL] [Abstract][Full Text] [Related]
18. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
[TBL] [Abstract][Full Text] [Related]
19. VEGF gene transfer for diabetic neuropathy.
Isner JM; Ropper A; Hirst K
Hum Gene Ther; 2001 Aug; 12(12):1593-4. PubMed ID: 11529248
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
Wymer JP; Simpson J; Sen D; Bongardt S;
Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
